Since activators of potassium channels are known to be used as drugs for epilepsy [31,32], it seems that TWIK-1 could be a novel therapeutic target for epilepsy and TWIK-1 functions in epilepsy should be examined in future studies. This evidence concerns the gene KCNA3 and epilepsy.